Mark as
Longitudinal Evaluation of Humoral Immunity Following Vaccination With Six ZIKV Vaccines
The immunogenicity and efficacy of Zika virus (ZIKV) vaccines from our lab were successfully exhibited in both murine and non-human primate models. Long-term protection, a hallmark for vaccines, and the humoral immunity kinetics, though, have not yet been elucidated. Furthermore, a side-to-side comparison of ZIKV vaccines such as human adenovirus (Ad) serotypes 5, 26, rhesus adenovirus (RhAd) serotype 52, DNA vectors and purified inactivated virus (PIV) has not been done. The Ad-based vaccines, expressing viral membrane/envelope proteins, and PIV conferred durable protection against ZIKV...
More by Kittipos Visitsunthorn
Recent activity
Rate this book to see your activity here.
Comments and reviews
Please sign in to leave a comment